文献速递肾移植

供体入院、最低及终末肌酐与肾移植结局的关联

Association of Admission, Nadir, and Terminal Donor Creatinine With Kidney Transplantation Outcomes.
PubMed 文献 · Kidney Int Rep · 2021-05-15

该研究基于澳大利亚和新西兰器官捐献与透析移植登记数据,纳入2003至2019年成人 deceased donor 单纯肾移植受者8971例,比较供体入院、终末及两者最高eGFR对受者结局的预测能力。结果显示三种eGFR均与DGF及受者6、12个月eGFR相关,且对移植物失败有强预测作用,终末eGFR预测稍优,尤其对近期结局。

要点

  • 供体终末eGFR对移植结局的预测略优于入院eGFR和最高eGFR。
  • 供体eGFR与DGF及受者6、12个月eGFR强相关,并预测移植物失败。
  • 建议将终末eGFR纳入风险方程以预测硬临床终点。

核心结论

  • 在评估 deceased 供肾时,终末eGFR对移植结局的预测略优于入院eGFR和最高eGFR,尤其对近期结局。
  • 终末eGFR应被用于风险方程以预测硬临床终点。

研究设计与样本

  • 基于澳大利亚和新西兰器官捐献与透析移植登记数据的回顾性队列研究。
  • 纳入2003至2019年成人 deceased donor 单纯肾移植受者共8971例。
  • 比较供体入院、终末及两者最高eGFR三种暴露变量对受者结局的预测能力。

主要发现

  • 终末、入院及最高供体eGFR与DGF和受者6、12个月eGFR之间存在强关联证据。
  • 供体eGFR是移植物失败和死亡删失移植物失败的强预测因子,但不预测患者死亡。
  • 终末eGFR比入院eGFR和最高eGFR预测更好,尤其对更近期的结局。

临床怎么用

  • 在 deceased 供肾评估和分配中,可优先参考终末eGFR以预测DGF和移植物失败风险。
  • 建议将终末eGFR纳入预测硬临床终点的风险方程。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: When assessing deceased kidney donors, a key factor in organ acceptance and allocation is donor kidney function. It is unclear whether terminal, admission, or the highest of terminal and admission donor estimated glomerular filtration rate (eGFR) most predicts recipient outcomes. METHODS: We examined which measurement best predicts outcomes. Using data from the Australia and New Zealand Organ Donation and Dialysis and Transplant Registries, we included adult recipients of deceased donor kidney-only transplants over 2003 to 2019. We compared the 3 different exposure variables of admission, terminal, or highest eGFR. We created logistic regression models for delayed graft function (DGF), multilinear regression models for 6- and 12-month eGFR, and Cox proportional hazards models for graft loss, death censored graft failure and patient death. RESULTS: A total of 8971 transplant recipients were included. There was strong evidence of an association between terminal, admission, and highest donor eGFR and DGF and recipient eGFR at 6 and 12 months. The eGFR was a strong predictor of graft and death censored graft failure, but not patient death. Terminal was a better predictor than admission and highest eGFR particularly for more contemporaneous outcomes. CONCLUSION: In assessing kidney donors, terminal eGFR were marginally better than admission and highest at predicting outcomes. Terminal eGFR should be used in risk equations to predict hard clinical endpoints.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Irish GL, Coates PT, Clayton PA, et al. Association of Admission, Nadir, and Terminal Donor Creatinine With Kidney Transplantation Outcomes. Kidney Int Rep. 2021. PMID: 34386656. doi:10.1016/j.ekir.2021.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。